NEW YORK: Johnson & Johnson plans to start testing its experimental COVID-19 vaccine in youths aged 12 to 18 as soon as possible, and the company’s previous experience with the same technology in a vaccine successfully used in children could give it a leg up with regulators. “We plan to go into children as soon as we possibly can, but …
Read More »Plans to test COVID-19 vaccine in ages 12-18 on the cards
October 31, 2020